What is the current Price Target for the Aptose Biosciences Inc. stock?

The average Aptose Biosciences Inc. target price is $12.75. This is 804.26% higher than the current stock price. The highest price target is 830.85%, the lowest is 795.39%. 3 Analysts have issued a price target Aptose Biosciences Inc. 2026 .

How high will the Aptose Biosciences Inc. stock rise?

No reliable answer can be given as to how high the Aptose Biosciences Inc. stock will rise. The performance of stocks, including the Aptose Biosciences Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Aptose Biosciences Inc. stock today?

The performance of Aptose Biosciences Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Aptose Biosciences Inc. stock fall?

The decline in Aptose Biosciences Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Aptose Biosciences Inc. Forecast, price target & analysts

$1.41

0.00%

Nasdaq, Fri, Nov 07 2025

ISIN

CA03835T2002

Symbol

APTO

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts Strategies

Aptose Biosciences Inc. Target price 2025 - Analyst rating & recommendation

Aptose Biosciences Inc. Classifications & Recommendation:

Buy

86%

Hold

14%

Aptose Biosciences Inc. Price Target

Target Price	$12.75
Price	$1.41
Potential	804.26% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Aptose Biosciences Inc. 2026 . The average Aptose Biosciences Inc. target price is $12.75. This is 804.26% register free of charge higher than the current stock price. The highest price target is $13.13 830.85% register free of charge , the lowest is $12.63 795.39% register free of charge .
	A rating was issued by 7 analysts: 6 Analysts recommend Aptose Biosciences Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Aptose Biosciences Inc. stock has an average upside potential 2026 of 804.26% register free of charge . Most analysts recommend the Aptose Biosciences Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '23	2024 Estimates
Earnings Per Share $	-227.44	-43.70
	11.50%	80.79%
P/E		negative

4 Analysts have issued a Aptose Biosciences Inc. forecast for earnings per share. The average Aptose Biosciences Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2023. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2023	$-227.44	11.50%
2024	$-43.70 80.79% Unlock
2025	$-2.23 94.90% Unlock
2026	$-1.79 19.73% Unlock

Current	-0.02	87.63%
2024	-0.03 22.95% Unlock
2025	-0.63 2,000.00% Unlock
2026	-0.79 25.40% Unlock

Aptose Biosciences Inc....

Current Aptose Biosciences Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 28 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 12 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 10 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Dec 10 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Dec 03 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 20 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 28 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 12 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 10 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Dec 10 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Dec 03 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 20 2024

Discover more stocks with a high price target

Novo Nordisk 60.25%

TUI 59.01%

Adidas 53.11%

Deutsche Telekom 45.39%

Meta Platforms (Facebook) 43.56%

Adyen 39.97%

BYD 38.89%

BioNTech SE - ADR 34.99%

Coinbase Global, Inc. 33.30%

Infineon 30.91%

Microsoft 29.34%

Netflix 28.46%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now